The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
HOME > LATEST
LATEST
-
BUSINESS Nipro, Samsung Bioepis Tie Up on Biosimilar Business in Japan
June 10, 2025
-
BUSINESS Sawai Follows Fuso to Challenge Remitch Patent Ruling
June 10, 2025
-
REGULATORY Honebuto Draft Urges Promotion of Drug Innovation, but Spells Out CEA Expansion Too
June 9, 2025
-
REGULATORY MSD’s Welireg, BMS’ Inrebic, J&J’s Talvey Now in Line for Japan Approval
June 9, 2025
-
BUSINESS Otsuka’s Sibeprenlimab Scores Positive Results in PIII: Interim Analysis
June 9, 2025
-
BUSINESS Sumitomo Divests Canadian Business to Knight
June 9, 2025
-
BUSINESS BMS Files Label Expansion of Sotyktu for Psoriatic Arthritis in Japan
June 9, 2025
-
BUSINESS Tivdak Offers Valuable New Option as 2nd-Line Cervical Cancer Therapy: Oncologist
June 9, 2025
-
REGULATORY MHLW to Share Guidelines on Order to Replace Company Officers under Amended PMD Act
June 9, 2025
-
BUSINESS Antibody Market to Reach 2.6 Trillion Yen in 2034: Fuji Keizai
June 9, 2025
-
REGULATORY 3 Parties Agree to Review OTC-Like Drugs from FY2026, but Details Still in the Air
June 9, 2025
-
BUSINESS Moderna Files Updated Spikevax for LP.8.1 Strain in Japan
June 9, 2025
-
BUSINESS Fuso Takes Remitch Patent Case to Top Court
June 9, 2025
-
BUSINESS Japan Ethical Drug Sales Up 1.2% in April: Crecon
June 9, 2025
-
BUSINESS Takeda Rolls Out AI Tool to Guide “Next Best Action” in Sales
June 6, 2025
-
BUSINESS Meiji, Daito to Launch Talks on New Consortium to Stabilize Generic Supply, Boost Profitability
June 6, 2025
-
BUSINESS Keytruda Japan’s Top-Selling Drug for 20th Month Running: Encise
June 6, 2025
-
BUSINESS Santen’s Myopia Drug Approved in Europe
June 6, 2025
-
ORGANIZATION Pharma FTC Revises Food and Drink Rules for Doctors for 1st Time in 10-Plus Years
June 5, 2025
-
BUSINESS Towa/CiRA to Launch PII/III Trial of Bromocriptine for Familial AD
June 5, 2025
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…